• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小汗腺癌:新见解及文献系统综述

Eccrine Porocarcinoma: New Insights and a Systematic Review of the Literature.

作者信息

Nazemi Azadeh, Higgins Shauna, Swift Reyna, In Gino, Miller Kimberly, Wysong Ashley

机构信息

Medical Oncology.

Preventative Medicine, and.

出版信息

Dermatol Surg. 2018 Oct;44(10):1247-1261. doi: 10.1097/DSS.0000000000001566.

DOI:10.1097/DSS.0000000000001566
PMID:29894433
Abstract

BACKGROUND

Eccrine porocarcinoma (EPC) is a rare cutaneous neoplasm with high potential for morbidity and mortality. Due to its rarity, there is a paucity of data profiling diagnosis, work-up, and management.

OBJECTIVE

To consolidate reported information on demographics, diagnostics, clinical behavior, treatment modalities, and patient outcomes in EPC to provide a reference tool to optimize diagnosis and management.

METHODS

A comprehensive PubMed search was performed from 1963 to November 2017 using PRISMA guidelines. This yielded 155 articles detailing 206 cases of porocarcinoma.

RESULTS

Eccrine porocarcinoma most often presents in elderly patients on the head and neck or lower limbs. Metastatic disease at presentation is not uncommon (22%). Primary tumor location is significantly correlated with presence of metastasis (p = .038). The most common treatment is excision followed by Mohs micrographic surgery (MMS), although the outcomes after MMS were superior to those after surgical excision.

CONCLUSION

This systematic review of individual patient data reveals that all patients should have a histological diagnosis with imaging considered for high-risk cases. Primary tumor location should also be considered in diagnostic and therapeutic decision-making. Although wide local excision (WLE) is currently the first-line treatment, MMS is becoming increasingly used, with evidence indicating improved outcomes as compared to those seen with WLE.

摘要

背景

小汗腺汗孔癌(EPC)是一种罕见的皮肤肿瘤,具有较高的发病和死亡风险。由于其罕见性,关于其诊断、检查及治疗的数据较少。

目的

汇总已报道的关于小汗腺汗孔癌的人口统计学、诊断、临床行为、治疗方式及患者预后的信息,以提供一个优化诊断和治疗的参考工具。

方法

按照PRISMA指南,于1963年至2017年11月在PubMed上进行全面检索。共获得155篇详细描述206例汗孔癌病例的文章。

结果

小汗腺汗孔癌最常发生于老年患者的头颈部或下肢。就诊时出现转移的情况并不少见(22%)。原发肿瘤部位与转移的发生显著相关(p = 0.038)。最常见的治疗方法是切除,随后进行莫氏显微外科手术(MMS),尽管MMS后的效果优于手术切除。

结论

对个体患者数据的这项系统评价表明,所有患者均应进行组织学诊断,高危病例需考虑影像学检查。在诊断和治疗决策中也应考虑原发肿瘤部位。尽管广泛局部切除(WLE)目前是一线治疗方法,但MMS的应用越来越多,有证据表明与WLE相比,其效果有所改善。

相似文献

1
Eccrine Porocarcinoma: New Insights and a Systematic Review of the Literature.小汗腺癌:新见解及文献系统综述
Dermatol Surg. 2018 Oct;44(10):1247-1261. doi: 10.1097/DSS.0000000000001566.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
9
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.

引用本文的文献

1
Eccrine carcinomas and homologous recombination repair cancer predisposition genes: A case series.外分泌腺癌与同源重组修复癌症易感基因:病例系列
JAAD Case Rep. 2025 Jul 12;64:128-134. doi: 10.1016/j.jdcr.2025.04.047. eCollection 2025 Oct.
2
Clinicopathological comparison of eccrine poroma and porocarcinoma: Ki-67 index is not a decisive factor.小汗腺汗孔瘤与汗孔癌的临床病理比较:Ki-67指数并非决定性因素。
PLoS One. 2025 May 30;20(5):e0324975. doi: 10.1371/journal.pone.0324975. eCollection 2025.
3
Elucidating Cytomorphological Features of Eccrine Porocarcinoma on The Forehead Presenting Without Pre-existing Poroma in an Adult Male: A Rarity Unveiled with a Comprehensive Review of Literature.
揭示一名成年男性前额部无先前汗孔瘤的情况下发生的小汗腺汗孔癌的细胞形态学特征:通过文献综述揭示的罕见病例
Indian J Surg Oncol. 2025 Apr;16(2):443-449. doi: 10.1007/s13193-024-02130-6. Epub 2024 Nov 25.
4
Eccrine malignancies in nevus sebaceus: Case presentation and review of the literature.皮脂腺痣中的小汗腺恶性肿瘤:病例报告及文献复习
JAAD Case Rep. 2025 Jan 13;57:59-63. doi: 10.1016/j.jdcr.2024.12.029. eCollection 2025 Mar.
5
Whole-exome sequencing identifies distinct genomic aberrations in eccrine porocarcinomas and poromas.全外显子组测序鉴定出小汗腺汗孔癌和汗孔瘤中不同的基因组畸变。
Orphanet J Rare Dis. 2025 Feb 13;20(1):70. doi: 10.1186/s13023-025-03586-7.
6
Sentinel Lymph Node Biopsy: Is There a Role in Non-Melanoma Skin Cancer? A Systematic Review.前哨淋巴结活检:在非黑色素瘤皮肤癌中是否有作用?一项系统评价。
Cancers (Basel). 2024 Dec 23;16(24):4279. doi: 10.3390/cancers16244279.
7
Eccrine poroma versus eccrine porocarcinoma: a comparative study of clinicopathological features.小汗腺汗孔瘤与小汗腺汗孔癌:临床病理特征的比较研究
An Bras Dermatol. 2025 Mar-Apr;100(2):253-259. doi: 10.1016/j.abd.2024.04.010. Epub 2024 Dec 12.
8
Diagnosis and Management of Malignant Epithelial Nail Unit Tumors.恶性上皮性甲单位肿瘤的诊断与管理
Diagnostics (Basel). 2024 Oct 25;14(21):2379. doi: 10.3390/diagnostics14212379.
9
Porocarcinoma: Clinical and Histological Features, Immunohistochemistry and Outcomes: A Systematic Review.**标题**: 派杰氏病:临床和组织学特征、免疫组化和结局:系统回顾 **摘要**:目的:本研究旨在对派杰氏病的临床和组织学特征、免疫组化表现和结局进行系统回顾。方法:我们检索了 MEDLINE、Embase 和 Cochrane 图书馆,以获取关于派杰氏病的研究。结果:我们纳入了 46 项研究,涵盖了 3064 例患者。派杰氏病最常发生于女性(67.5%),中位年龄为 70 岁(范围:21-100 岁)。最常见的受累部位为乳房(55.4%),其次为外阴(24.4%)和肛周区域(10.1%)。临床特征包括瘙痒性斑块、红斑和/或脱屑。组织学特征包括表皮内有特征性的胞质内空泡的细胞巢和/或条索,以及真皮内的淋巴细胞浸润。免疫组化通常显示细胞角蛋白 7(CK7)和细胞角蛋白 20(CK20)的表达,而 EMA 和 Ber-EP4 也可用于辅助诊断。大多数患者接受了手术治疗,包括局部切除和广泛切除。局部复发率为 20.1%,转移率为 14.3%。结论:派杰氏病是一种罕见的疾病,具有独特的临床和组织学特征。免疫组化在诊断中具有重要作用,尤其是 CK7 和 CK20 的表达。治疗主要是手术切除,局部复发和转移的风险较高。
Int J Mol Sci. 2024 May 25;25(11):5760. doi: 10.3390/ijms25115760.
10
Navigating Head and Neck Porocarcinoma: Systematic Review with Special Emphasis on Surgical Safety Margins.头颈部鼻窦癌的诊疗:特别关注手术切缘的系统评价
Cancers (Basel). 2024 Mar 24;16(7):1264. doi: 10.3390/cancers16071264.